CIBC World Market’s CareDx CDNA Stock Holding History

CIBC World Market’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,840	Closed	-$874K	–	1340
2021 Q1	$874K	Buy	+12,840	New	+$997K	﹤0.01%	808

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

CIBC World Market's CDNA Position: Q2 2021 in Review

CIBC World Market sold out of CareDx (CDNA) in Q2 2021, closing a stake of 12,840 shares — an estimated $874K sold.

CIBC World Market first reported a position in CDNA in Q1 2021 and held it in 1 quarter. The position peaked at $874K in Q1 2021. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.

CIBC World Market reported no remaining CareDx position as of Q2 2021 after selling out during the quarter.
CIBC World Market sold 12,840 CareDx shares in Q2 2021, an estimated $874K.
CIBC World Market first reported a position in CareDx in Q1 2021 and held it in 1 quarter.
CIBC World Market's CareDx position peaked at $874K in Q1 2021.
254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.

Based on CIBC World Market's 13F filing for Q2 2021, filed 12 Aug 2021.